Economy Bloomberg 1h ago

Lilly Strikes Deal for Orna Therapeutics for Up to $2.4 Billion

Market Intelligence Analysis

AI-Powered
Why This Matters

Eli Lilly & Co has agreed to acquire Orna Therapeutics Inc. for up to $2.4 billion in cash, marking another significant deal for the company.

Market Impact

Market impact analysis based on bullish sentiment with 90% confidence.

Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Eli Lilly & Co agreed to buy US biotech Orna Therapeutics Inc. for up $2.4 billion in cash in the latest deal by the company best known for its weight-loss drug Zepbound.

Continue Reading
Full article on Bloomberg
Read Full Article

Related Articles

Economy 30m ago

Brazil Tapping Global Debt Markets After Busiest Year in Decades

Brazil is tapping global debt markets after a record-breaking year of issuance, indicating a possible …
Economy 1h ago

RBC says last week’s pullback in stocks likely short lived

RBC Capital believes last week's stock market pullback is unlikely to be the start of …
Economy 1h ago

Transocean Agrees to Buy Valaris for $5.8 Billion in Stock

Transocean Ltd. agreed to acquire Valaris Ltd. in an all-stock deal worth $5.8 billion, driven …
Economy 44m ago

Nordic Power Prices Jump to Highest Since Energy Crisis in 2022

Nordic power prices have reached their highest level since the 2022 energy crisis due to …
Economy 56m ago

IMF Chief Plays Down the Dollar’s ‘Short Term Variations’

The IMF Chief downplayed the dollar's decline, stating it will retain its preeminent position, indicating …
Economy 1h ago

Villeroy Quits Bank of France, Letting Macron Pick Next Governor

Bank of France Governor Francois Villeroy de Galhau has unexpectedly resigned, allowing French President Emmanuel …
Original article published by Bloomberg on February 9, 2026.
Analysis and insights provided by AnalystMarkets AI.